Head-to-head · Cost-Efficiency Index
Aquivia Health vs Oria Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Aquivia Health
Cost-first shoppers who want clinician-reviewed compounded GLP-1 with optional branded upgrade.
Visit Aquivia HealthOria Meds
Readers who want the dispensing pharmacy named with an address and will complete the intake to see the real plan menu.
Visit Oria MedsThe verdict
Aquivia Health and Oria Meds tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with Aquivia Health (ranked #207, a hair above #209) — Cost-first shoppers who want clinician-reviewed compounded GLP-1 with optional branded upgrade. But Oria Meds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Aquivia Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Aquivia Health | Oria Meds |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $149/mo | $199/month month-to-month (read in the intake; the homepage's $149 appears nowhere in the funnel) |
| Tirzepatide / mo | $179/mo | $369/month month-to-month (the homepage's $249 appears nowhere in the funnel) |
| Semaglutide / yr (modeled) | $1,788 | $2,388 |
| Tirzepatide / yr (modeled) | $2,148 | $4,428 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #207 | #209 |
Aquivia Health
62/100Where the value is
- Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
- Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
- Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
The tradeoffs
- No public list of states served — you must complete intake to learn if your state qualifies
- No named 503A compounding pharmacy partner, limiting licensure verification
Oria Meds
62/100Where the value is
- Names its compounding pharmacy, PerfectRx, with a street address, phone number and website
- The monthly figure covers free shipping, a home injection kit, free dose increases and unlimited medical support, itemized on the plan card
- Names the provider network behind the prescriptions rather than referring only to licensed clinicians
The tradeoffs
- Neither published floor exists in the funnel: "starting at $149" and "starting at $249" appear nowhere in the plan menu, which offers $199 and $369
- The semaglutide ladder is inverted — one month is $199 while three and six months are both $209 a month, so committing longer costs more
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.